0.8281
price down icon1.76%   -0.0148
 
loading

Context Therapeutics Inc Azioni (CNTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Income/Loss
76.49%
-9.7584
-5.5291 -4.3104 -18.70 -3.0885
Income/Loss From Continuing Operations Before Tax
92.86%
-8.8275
-4.5773 -28.96 1.2437 -2.2545
Income/Loss From Continuing Operations After Tax
92.86%
-8.8275
-4.5773 -3.3429 -17.46 -2.2545
Net Income/Loss
92.86%
-8.8275
-4.5773 -3.3429 -17.46 -2.2545
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
95.19
95.19 7.838 80.48 54.96
Diluted Average Shares
0.00%
95.19
95.19 7.838 80.48 54.96
Basic Earnings Per Share
80.00%
-0.09
-0.05 - -0.22 -0.04
Diluted Earnings Per Share
80.00%
-0.09
-0.05 - -0.22 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):